Review

Consensus Best Practice pathway of the UK Scleroderma Study Group: gastrointestinal manifestations of systemic sclerosis

N. Hansi, N. Thoua, M. Carulli, K. Chakravarty, S. Lal, A. Smyth, A.L. Herrick, O. Ogunbiyi, J. Shaffer, J. Mclaughlin, C.P. Denton, V.H. Ong, A.V. Emmanuel, C.D. Murray

CER7611
2014 Vol.32, N°6 ,Suppl.86
PI 0214, PF 0221
Review

Free to view
(click on article PDF icon to read the article)

PMID: 25372804 [PubMed]

Received: 22/05/2014
Accepted : 09/10/2014
In Press: 05/11/2014
Published: 05/11/2014

Abstract

Systemic sclerosis is an autoimmune connective tissue disorder, which can be progressive with multisystem involvement. Guidance on the management of complications is based on a limited data set and practice amongst clinicians can vary. The UK Scleroderma study group set up several working groups to agree some consensus pathways for the management of specific complications. Approximately nine out of ten patients with systemic sclerosis will have involvement of the gastrointestinal system and in this review article we explore the management of these complications in a symptom-based approach. The algorithms are a useful tool for clinicians, which we hope, will be a point of reference and highlight the need for further research in these areas.